Nurse-led education and tele-interventions to reduce infections after heart surgery

The Effect of Patient Education and Implementation of Teleinterventions by Nurses, on the Incidence of Surgical Wound Infections, in Patients After Coronary Artery Bypass Surgery

Not applicable Interventional Hellenic Mediterranean University · NCT06586749

This study is testing if teaching patients about care after heart surgery and using phone support can help reduce infections and improve recovery.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment220 (estimated)
Ages18 Years and up
SexAll
SponsorHellenic Mediterranean University Academic / other
Locations1 site (Heraklion, Crete)
Trial IDNCT06586749 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to evaluate the effectiveness of nurse-led education and tele-interventions in reducing surgical site infections in patients who have undergone coronary artery bypass surgery. Participants will be divided into three groups: one receiving standard postoperative care, another receiving nurse-led education, and a third receiving both nurse-led education and tele-interventions. The study will monitor infection rates and assess the impact of these interventions on patient outcomes. The goal is to determine if these educational and telehealth strategies can improve recovery and reduce complications.

Who should consider this trial

Good fit: Ideal candidates are adults aged 18 and older who have undergone CABG surgery and are at intermediate or high risk for developing surgical site infections.

Not a fit: Patients with a history of psychiatric illness, recent substance abuse, or those undergoing concurrent surgeries may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly lower the incidence of surgical site infections, leading to better recovery outcomes for patients.

How similar studies have performed: While similar approaches have been explored, this specific combination of nurse-led education and tele-interventions in the context of CABG surgery is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Patients who have undergone CABG with median sternotomy
* Proficiency in reading and writing in Greek
* Patients who provide written informed consent for participation in the study
* Patients who have access to a mobile phone and know how to use it
* Patients without difficulties in vision, speech, or hearing
* Patients at intermediate or high risk for developing surgical site infections, based on their scores in the risk stratification models described below

Exclusion Criteria:

* History of psychiatric illness, recent history of alcohol and/or substance abuse, dementia, and Alzheimer's disease
* Presence of an active infection within 2 weeks prior to the surgical procedure
* Preoperative hospitalization \> 2 days
* Concurrent surgery on the aorta or heart valves
* Urgent or emergency nature of the surgical procedure
* Re-sternotomy aimed at surgical re-exploration of bleeding or implementation of cardiopulmonary resuscitation (CPR) in cases of cardiac arrest
* Patients in whom the sternum has not been closed after the completion of the surgical procedure and who are transferred to the cardiothoracic unit without sternum closure
* Active endocarditis
* Life expectancy \< 6 months
* Lack of a smartphone

Where this trial is running

Heraklion, Crete

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Surgical Site InfectionCoronary Artery Bypass Grafting
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.